Clinical trial
A Single-Dose, Open-Label Comparative Study of the Pharmacokinetics, Safety,and Tolerability of Oral Quinine Sulfate in Healthy Volunteers and Adults With Mild and Moderate Renal Impairment
NCT00785551 is registered in ClinicalTrials.gov with Mutual Pharmaceutical Company, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single-Dose, Open-Label Comparative Study of the Pharmacokinetics, Safety,and Tolerability of Oral Quinine Sulfate in Healthy Volunteers and Adults With Mild and Moderate Renal Impairment
- Lead sponsor
- Mutual Pharmaceutical Company, Inc.
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- November 30, 2007
- Completion date
- January 31, 2011
- Enrollment
- 5 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy, renal impairment